Issued Patents All Time
Showing 1–25 of 50 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11964989 | KRas G12D inhibitors | Xiaolun Wang, Aaron Craig Burns, James Gail Christensen, John Michael Ketcham, John David Lawson +21 more | 2024-04-23 |
| 11453683 | KRas G12D inhibitors | Xiaolun Wang, Aaron Craig Burns, James Gail Christensen, John Michael Ketcham, John David Lawson +21 more | 2022-09-27 |
| 9849113 | Methods of treating α adrenergic mediated conditions | Daniel W. Gil, John E. Donello, Wenkui K. Fang, Ken Chow, Todd M. Heidelbaugh +3 more | 2017-12-26 |
| 9623006 | Methods of treating α adrenergic mediated conditions | Daniel W. Gil, John E. Donello, Wenkui K. Fang, Ken Chow, Todd M. Heidelbaugh +3 more | 2017-04-18 |
| 9572792 | Coumarin compounds as receptor modulators with therapeutic utility | Todd M. Heidelbaugh, John R. Cappiello, Dario G. Gomez | 2017-02-21 |
| 9073888 | Coumarin compounds as receptor modulators with therapeutic utility | Todd M. Heidelbaugh, John R. Cappiello, Dario G. Gomez | 2015-07-07 |
| 9034910 | Methods of treating alpha adrenergic mediated conditions | Daniel W. Gil, John E. Donello, Wenkui K. Fang, Ken Chow, Todd M. Heidelbaugh +3 more | 2015-05-19 |
| 8828973 | Compounds as receptor modulators with therapeutic utility | Todd M. Heidelbaugh, John R. Cappiello | 2014-09-09 |
| 8809379 | Selective subtype alpha 2 adrenergic agents and methods for use thereof | Todd M. Heidelbaugh, Ken Chow, Santosh C. Sinha, Ling Li, Wenkui K. Fang +2 more | 2014-08-19 |
| 8741875 | Compounds as receptor modulators with therapeutic utility | Todd M. Heidelbaugh, John R. Cappiello | 2014-06-03 |
| 8735399 | Selective subtype alpha 2 adrenergic agents and methods for use thereof | Todd M. Heidelbaugh, Ken Chow, Santosh C. Sinha, Wenkui K. Fang, Ling Li +2 more | 2014-05-27 |
| 8703746 | Compounds as receptor modulators with therapeutic utility | Todd M. Heidelbaugh | 2014-04-22 |
| 8703745 | Compounds as receptor modulators with therapeutic utility | Todd M. Heidelbaugh | 2014-04-22 |
| 8653270 | Compounds as receptor modulators with therapeutic utility | Todd M. Heidelbaugh | 2014-02-18 |
| 8653062 | Compounds as receptor modulators with therapeutic utility | Todd M. Heidelbaugh | 2014-02-18 |
| 8486985 | Selective subtype alpha 2 adrenergic agents and methods for use thereof | Ken Chow, Todd M. Heidelbaugh | 2013-07-16 |
| 8440644 | Compounds as receptor modulators with therapeutic utility | Todd M. Heidelbaugh | 2013-05-14 |
| 8383646 | Therapeutic ((bicylicheteroaryl)imidazolyl) methylheteroaryl compounds | Santosh C. Sinha, Todd M. Heidelbaugh, Ken Chow, Smita S. Bhat, Michael E. Garst | 2013-02-26 |
| 8362022 | Selective subtype alpha 2 adrenergic agents and methods for use thereof | Todd M. Heidelbaugh, Ken Chow, Santosh C. Sinha, Wenkui K. Fang, Ling Li +2 more | 2013-01-29 |
| 8329918 | Selective alpha 2B/2C agonists | Ken Chow, Todd M. Heidelbaugh, Dario G. Gomez, Wenkui K. Fang, Santosh C. Sinha +2 more | 2012-12-11 |
| 8258167 | Naphthylmethylimidizoles as therapeutic agents | Todd M. Heidelbaugh, Ken Chow, Michael E. Garst | 2012-09-04 |
| 8183414 | N-(1-phenyl-2-arylethyl)-4,5-dihydro-2H-pyrrol-5-amine compounds as subtype selective modulators of ALPHA2B or ALPHA2B and ALPHA2C adrenoceptors | Ken Chow, Janet A. Takeuchi, Ling Li, Todd M. Heidelbaugh, Evelyn G. Corpuz +3 more | 2012-05-22 |
| 8178571 | Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same | Todd M. Heidelbaugh, Ken Chow, Daniel W. Gil, John E. Donello, Michael E. Garst +2 more | 2012-05-15 |
| 8168795 | Selective sphingosine-1-phosphate receptor antagonists | Todd M. Heidelbaugh, Ken Chow, Michael E. Garst | 2012-05-01 |
| 8119807 | Quinolynylmethylimidizoles as therapeutic agents | Todd M. Heidelbaugh, Ken Chow, Michael E. Garst | 2012-02-21 |